Somatuline Depot
Generic name: Lanreotide
Drug class:
Somatostatin and somatostatin analogs
Usage of Somatuline Depot
Somatuline Depot (lanreotide) is a man-made protein similar to a hormone in the body called somatostatin. Lanreotide lowers many substances in the body such as insulin and glucagon (involved in regulating blood sugar), growth hormone, and chemicals that affect digestion.
Somatuline Depo is used in adults to treat:
Somatuline Depo is sometimes given after other treatments have failed.
Somatuline Depot side effects
Get emergency medical help if you have signs of an allergic reaction to Somatuline Depot: hives; difficult breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have:
Common Somatuline Depot side effects may include:
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Before taking Somatuline Depot
You should not use Somatuline Depo if you are allergic to lanreotide.
To make sure Somatuline Depot is safe for you, tell your doctor if you have ever had:
It is not known whether lanreotide will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant.
Somatuline Depo may affect fertility (your ability to have children) in women.
You should not breast-feed while using Somatuline Depo and for at least 6 months after your last dose.
Relate drugs
- Mycapssa
- Bynfezia Pen
- Lanreotide
- Octreotide (Injection, Intramuscular, Subcutaneous)
- Octreotide (Oral)
- Octreotide oral/injection
- Pasireotide
- Sandostatin
- Sandostatin LAR Depot
- Signifor
- Signifor LAR
- Somatuline Depot
How to use Somatuline Depot
Usual Adult Dose for Acromegaly:
Initial dose: 90 mg, by deep suBCutaneous injection, every 4 weeks for 3 months Comments: -The goal of treatment is to reduce growth hormone (GH) and insulin-like growth factor (IGF-1) levels to normal. -Adjust dose after initial 3 months. -No dose adjustment is required for elderly patients. Use: Long-term treatment of acromegalic patients who have had an inadequate response to surgery and/or radiotherapy, or for whom surgery and/or radiotherapy is not an option.
Usual Adult Dose for Neuroendocrine Carcinoma:
120 mg, by deep subcutaneous injection, every 4 weeks Comments: No dose adjustment is required for elderly patients. Use: Treatment of patients with unresectable, well or moderately-differentiated, locally advanced, or metastatic gastroenteropancreatic neuroendocrine tumors (GEP-NETs) to improve progression-free survival.
Usual Adult Dose for Carcinoid Syndrome:
120 mg by deep subcutaneous injection every 4 weeks Comments: If patients are already being treated for GEP-NETs, do not administer an additional dose for the treatment of carcinoid syndrome. Use: For the treatment of carcinoid syndrome; when used, it reduces the frequency of short-acting somatostatin analog rescue therapy.
Warnings
Follow all directions on your medicine label and package. Tell each of your healthcare providers about all your medical conditions, allergies, and all medicines you use.
Especially tell your healthcare provider if you take:
What other drugs will affect Somatuline Depot
When you start or stop taking Somatuline Depo, your doctor may need to adjust the doses of any other medicines you take on a regular basis.
Tell your doctor about all your other medicines, especially:
This list is not complete. Other drugs may interact with lanreotide, including prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible drug interactions are listed here.
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions